Masimo and Philips Expand Strategic Partnership to Accelerate Innovation in Patient Monitoring
Masimo and Royal Philips have announced the renewal and expansion of their long-standing strategic partnership, aimed at enhancing patient monitoring technologies and advancing healthcare delivery. This multi-year partnership will focus on integrating Masimo’s cutting-edge monitoring solutions into Philips’ multi-parameter patient monitors, with a special emphasis on wearable and AI-based technologies. The collaboration will support the seamless integration of Masimo’s SET® pulse oximetry, Radius PPG®, and other advanced sensor technologies into Philips devices, including bedside monitors, central stations, and wearable solutions.
The expanded partnership builds on over two decades of successful collaboration, during which Masimo’s technologies have become integral to Philips’ offerings. As part of the renewal, the companies will expedite the adoption of these advanced monitoring capabilities, extending their use across additional market segments and healthcare settings. This includes providing clinicians with real-time, actionable data to improve patient care throughout the continuum, from hospital beds to at-home monitoring solutions.
Philips, known for its leadership in health technology, and Masimo, a pioneer in noninvasive monitoring, have set their sights on co-developing the next generation of monitoring technologies that integrate artificial intelligence. These innovations will help clinicians make faster, more informed decisions, ultimately leading to improved patient outcomes. The companies also plan to collaborate on expanding access to these technologies, making them more widely available to healthcare providers globally.
“We are excited to continue our partnership with Philips, which has allowed us to integrate Masimo’s newest innovations into their platforms,” said Katie Szyman, CEO of Masimo. “This expanded partnership will enable us to reach more patients, providing them with the best-in-class monitoring technologies that support enhanced clinical decision-making.”
Julia Strandberg, Executive Vice President at Philips, emphasized that the partnership aims to provide clinicians with tools that not only meet current demands but also anticipate future needs. “By integrating proven technologies into scalable, user-friendly solutions, we can help healthcare providers stay ahead of evolving clinical trends and improve patient care,” she said.
A key feature of the renewed collaboration is the focus on reducing system complexity while enhancing interoperability across healthcare devices. By combining Philips’ established monitoring platforms with Masimo’s advanced technologies, the two companies aim to deliver more efficient and flexible solutions that support continuous care for patients across various clinical environments.
The partnership also reflects a shared commitment to advancing smart, connected care. Both companies plan to develop next-generation solutions designed to improve patient mobility and address emerging healthcare challenges. This collaboration is expected to have a significant impact on the future of patient monitoring, helping to shape the next wave of healthcare innovation.
With this renewed collaboration, Masimo and Philips are positioning themselves to meet the growing demand for integrated, AI-powered monitoring solutions that enhance both clinical outcomes and operational efficiencies in healthcare systems worldwide.
